Concert Bio, a biotechnology startup founded in 2021 and based in the United Kingdom, is dedicated to "Transforming humanity’s relationship with microbes." Through their innovative approach, Concert Bio assists growers in harnessing their microbiome, combining monitoring with analytics to develop interventions that enhance the microbiome that matters most. The company's pilot program for soilless agriculture growers is currently operational and open to partnerships. Concert Bio recently secured a noteworthy £1.00M grant investment on 01 August 2023, with backing from Innovate UK and the Biotechnology and Biological Sciences Research Council. The strategic focus on leveraging microbiome solutions makes Concert Bio a promising player in the biotechnology industry.
General Information
Get notified when Concert Bio moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Concert Bio
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United Kingdom Market
Biotechnology
About Concert Bio
Taxonomy: microbiome monitoring, microbial analytics, soilless agriculture, agricultural microbiome, microbial interventions, microbial community optimization, agricultural technology, agricultural innovation
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Grant | •••••• | 2 |
|
01 Aug 2023 |
| Grant | •••••• | 2 |
|
31 May 2023 |
| Grant | •••••• | 1 |
|
06 Dec 2022 |
| Pre Seed Round | •••••• | 5 |
|
01 Aug 2022 |
Concert Bio Alternatives & Competitors
Our focus is on detailed understanding of the ‘invisible microbial life’ inside all of us.
Harnessing microbiome power for innovative postbiotics in human and animal wellness
FAQ About Concert Bio
Don't just browse. Track.
Signal Tracker monitors Concert Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.